With age, you may experience a loss of volume and structural support in the face. Most single-agent dermal fillers cannot individually provide the combined benefits of a hyaluronic acid lift and lasting collagen stimulation from calcium hydroxyapatite. HArmonyCa™ Lidocaine, known as HArmonyCa™, is a new dual-effect Hybrid Injectable combining hyaluronic acid (HA) with calcium hydroxyapatite (CaHA).
HArmonyCa is a dermal filler intended for facial soft tissue augmentation and injected into the deep dermal and sub-dermal layers. The product's lidocaine reduces pain during treatment, and the CaHA encourages related remodelling and collagen formation that can last up to 12 months.
HArmonyCa may improve skin architecture by providing an immediate lift from HA and a sustained lifting effect from new collagen production associated with CaHA.
Supporting the body's collagen production CaHA works deep within the dermis to form a scaffold for the internal growth of fibroblasts, helping to:
HA particles diffuse between collagen fibres of the lower dermal layer, which may create volume for an immediate lifting effect.
HArmonyCa may be suitable for:
The most common AEs after injection with HArmonyCa are mild and typical injection-site reactions.
Treatment with HArmonyCa is for UK adults of 18 years or over only.
To celebrate the launch of our new HArmonyCa™ treatment, available only in a few UK Aesthetics clinics, there's an introductory price of just £750, so get in quick.